Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Vitreoretinal Diseases and Surgery
What factors will most influence your decision to offer ENCELTO to patients with macular telangiectasia type 2?
Related Questions
How do you manage macular-threatening toxoplasma chorioretinitis in pregnancy?
How do you determine whether to switch to a different anti-VEGF agent or to Ozurdex after a patient with diabetic macular edema fails a series of Avastin?
How do you incorporate intravitreal methotrexate injections into the management of traumatic retinal detachment repairs?
If a patient is legally blind and on hydroxychloroquine, do you still recommend follow up with ophthalmology to monitor for hydroxychloroquine retinal toxicity?
When should delayed removal of an intraocular foreign body be considered?
Does using a heads-up display for surgery improve ergonomics and surgical performance compared to a traditional microscope, or does the need to alternate between views reduce its long-term usability?
What long-term complications have you observed in previously stable preterm infants with incomplete peripheral retinal vascularization who did not undergo ROP laser treatment?
Is there a role for PDT in a young patient with PXE and bilateral CNVM who requires intravitreal anti-VEGF injections every 4 weeks and is beginning to develop atrophy?
How do you manage a situation where the lens optic shifts in front of the iris after a Yamane technique?
How should diabetic retinopathy surveillance be adjusted for patients starting GLP-1 agonists?
